Group 1 30 mg edoxaban plus 2.5 mg prasugrel | Group 2 30 mg edoxaban plus 3.75 mg prasugrel | |
---|---|---|
n = 12 | n = 12 | |
Baseline | ||
Mean (SD) | 3.2 (0.8) | 3.5 (1.1) |
Median (IQR) | 3.0 (2.5–3.8) | 3.5 (2.5–4.5) |
Edoxaban administration | ||
Mean (SD) | 3.5 (0.6) | 4.7 (1.6) |
Median (IQR) | 3.5 (3.0–4.0) | 4.5 (3.3–6.0) |
Edoxaban plus prasugrel administration | ||
Mean (SD) | 5.4 (2.3) | 7.3 (2.8) |
Median (IQR) | 5.0 (3.5–7.3) | 7.5 (5.5–10.0) |